Features
As AI continues to transform industries, patent systems around the world are wrestling with the implications.
Waymo’s IP leaders explain how intangible assets have enabled it to pull ahead.
Despite a startling drop in applications, this year’s IAM/ktMINE ranking shows that financial institutions are ramping up activity.
With companies vying for prime position in this runaway sector, US rights holders still face severe obstacles in prosecuting quality patents.
Price differentiation could prove key to the latest iteration of wireless technology.
Court documents uncover a growing number of licensing players turning to litigation in China, but the results highlight myriad issues to resolve.
The growing body of disputes involving biologics innovators offers invaluable lessons.
After 18 months as head of the European Patent Office, António Campinos shares his vision for the agency's future and talks quality, AI, the UPC, competition between the IP5, getting the examiner corps onside and plenty more on top
What recent case law can teach us about protecting claims in the United States.
The key Patent Re-examination Board rules for post-issuance proceedings.
We talk to industry experts about fully exploiting new analysis platforms.
Consistency is key to overcome diverging approaches to applications.
Co-published
Experts from around the world share their insights on patent-eligible subject matter.
Columns
The legal education sector will need shaking up if it is to meet the evolving demands for legal knowledge.
We analyse 10 years of change for crucial clues as to what lies in store for the 2020s.
A close look at how the media has covered the high-profile lawsuit shows there may have been a significant shift in IP coverage.
Insights
Asset sales, trade wars and new names at the top made last year transformative for IP owners.
A rundown of some of the top news stories on the IAM platform in December, January and February.
Data centre
An in-depth analysis of medical technology-related patent portfolios reveals that Johnson & Johnson is the second largest innovator in the field, owning a significant number of high-quality patents in crucial sectors such as image analysis and AI.
